Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,676–3,700 of 27,380 studies, newest first · page 148 of 1096.

July 2025 25

  1. 2025-07-22

    Trends and forecasts of the prevalence and mortality of Alzheimer’s disease and other dementias in China

    ✓ Peer-reviewed How common it is Frontiers in Public Health

    Key finding: In 2021, the age-standardized prevalence of AD and other dementia in China was 1,194 per 100,000 (95% CI: 1018-1,383), and the mortality rate was 35 per 100,000 (95% CI: 9-93). +4 more findings

  2. 2025-07-22

    Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study

    ✓ Peer-reviewed Prevention and risk Diabetes Care

    Key finding: Adults were more likely than children to screen positive for a single autoantibody (4.0% vs. 2.6%) but less likely for multiple autoantibodies (0.83% vs. 2.8%; P < 0.001). +4 more findings

  3. 2025-07-22

    High-fat diet may increase the risk of insulin resistance by inducing dysbiosis

    ✓ Peer-reviewed Prevention and risk Metabolism Open

    Key finding: These findings may clarify valuable preventive and therapeutic targets for countermeasures to IR in people who use the Western diet.

  4. 2025-07-22
  5. 2025-07-22

    Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults With Type 2 Diabetes: A Target Trial Emulation

    ✓ Peer-reviewed Prevention and risk Annals of Internal Medicine

    Key finding: Among older adults with diabetes, no clear evidence was found that the incidence of dementia differed overall between patients using GLP-1RAs versus DPP4is. +3 more findings

  6. 2025-07-21

    Cell-type-directed network-correcting combination therapy for Alzheimer's disease

    ✓ Peer-reviewed Genetics Cell

    Key finding: Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by heterogeneous molecular changes across diverse cell types, posing significant challenges for treatment development. +2 more findings

  7. 2025-07-21

    Curcumin and Dementia: A Systematic Review of Its Effects on Oxidative Stress and Cognitive Outcomes in Animal Models

    ✓ Peer-reviewed Disease mechanisms International journal of molecular sciences

    Key finding: All studies assessing malondialdehyde (MDA) reported significant reductions, indicating reduced oxidative stress. +3 more findings

  8. 2025-07-21

    A normative calculator for MoCA domain scores: proxy for Z-scores of conventional neuropsychological tests

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s Research & Therapy

    Key finding: MDS varied significantly by age, sex, education, and language of administration even among participants with normal cognition. +4 more findings

  9. 2025-07-21

    Finger tapping and paratonia assessment in older adults with and without Mild cognitive impairment, motor-cognitive correlations

    ✓ Peer-reviewed Mild cognitive impairment Applied Neuropsychology Adult

    Key finding: Cognitively Impaired participants exhibited a prolonged strike duration compared to healthy participants. +2 more findings

  10. 2025-07-21

    The global, regional, and national burden and attributable risk factors of Alzheimer's disease and other dementias, 1990-2021: A systematic analysis for the Global Burden of Disease Study

    ✓ Peer-reviewed Risk factors Journal of Alzheimer s Disease

    Key finding: Smoking was identified as the primary risk factor for dementia burden among males, whereas obesity was the leading risk factor for females. +2 more findings

  11. 2025-07-21

    A Comparative Study of Burden of Care, Anxiety, and Well-Being Among Family Caregivers of Elderly with Dementia: Evidence from Kuwait

    ✓ Peer-reviewed Caregiving Healthcare

    Key finding: This study included 180 (65%) caregivers for the elderly with dementia and 98 (35%) without dementia. +4 more findings

  12. 2025-07-21
  13. 2025-07-21

    Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment

    ✓ Peer-reviewed Prevention and risk Nutrients

    Key finding: Clinicians treating obesity should be aware of their own biases, make efforts to reduce stigmatizing experiences in their practice, and address weight stigma in their treatment plans as needed. +4 more findings

  14. 2025-07-21

    Reduced retinal thickness and risk of Alzheimer’s disease: a bidirectional two-sample Mendelian randomization study

    ✓ Peer-reviewed Genetics Ageing and Neurodegenerative Diseases

    Key finding: No significant associations were found between retinal thickness and AD risk (RNFL: odds ratio [OR]IVW = 1.001, 95% confidence interval [CI] = 0.986-1.017, P = 0.883; GCIPL: ORIVW = 1.008, 95% CI = 0.997-1.019, P = 0.172). +4 more findings

  15. 2025-07-21

    Combating Genetic Heterogeneity for Polygenic Prediction of Susceptibility to Brain β-Amyloid Deposition

    ✓ Peer-reviewed Genetics Neurology Genetics

    Key finding: The APOE (apolipoprotein E) ε4 allele is the strongest known genetic risk factor for sporadic Alzheimer disease (AD) and for brain amyloidosis, an early marker of disease pathophysiology. +3 more findings

  16. 2025-07-20

    Genetic Correlates of Presenile Dementia and Cognitive Decline in the Armenian Population Following COVID-19: A Case-Control Study

    ✓ Peer-reviewed Getting a diagnosis International Journal of Molecular Sciences

    Key finding: Lower cognitive performance was associated with CNVs in PSEN1 (exons 1, 9, 12), GRN (exons 1, 6, 12), and MAPT (exons 2, 8), along with viral infections (HSV-1, HSV-2, HAV-2). +1 more finding

  17. 2025-07-19

    Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies

    ✓ Peer-reviewed Treatments Alzheimer's & dementia (New York, N. Y.)

    Key finding: We found that 51.9% of DLB patients were ever prescribed a ChEI, and those who were prescribed a ChEI had a greater diagnosis interval. +4 more findings

  18. 2025-07-19

    High-fidelity and differential nonsense suppression in live cells and a frontotemporal dementia allele with human transfer RNAs

    ✓ Peer-reviewed Lewy body dementia Nucleic Acids Research

    Key finding: With tRNA sequencing, we showed that a suppressor tRNA derived from the TCG-3-1 gene was expressed 2.1-fold higher and generated 1.8-fold more nonsense suppression than a tRNA derived from the TCG-4-1 gene. +1 more finding

  19. 2025-07-18

    Impaired BDNF-TrkB trafficking and signalling in Down syndrome basal forebrain neurons

    ✓ Peer-reviewed Down syndrome and Alzheimer's Cell death & disease

    Key finding: Individuals with Down syndrome (DS) are at an increased risk of developing AD compared to the general population. +4 more findings

  20. 2025-07-18
  21. 2025-07-18

    An inflammatory fingerprint in mild cognitively impaired patients is reversed by physical and cognitive training

    ✓ Peer-reviewed Prevention trials Brain Behavior & Immunity - Health

    Key finding: At baseline, MCI participants displayed elevated levels of IL-17A, CX3CL1, CCL11, with a borderline increase of IL-6 and TNFα. +4 more findings

  22. 2025-07-17

    Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Genome biology

    Key finding: Using cross-population GWAS meta-analyses, we identify novel LOAD susceptibility loci in/near LRRC4C and LHX5-AS1, both with known roles in neuronal development, as well as several novel population-unique loci.

  23. 2025-07-17

    Community Socioeconomic Disadvantage relates to White Matter Hyperintensity Burden in Mid-to-Late Life Adults

    ✓ Peer-reviewed Risk factors Biopsychosocial science and medicine

    Key finding: Linear regression models showed that higher community deprivation on the ADI associated with greater WMH volume, independently of age, sex, years of education and smoking.

  24. 2025-07-17

    Novel Dual Mechanism GRT-X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media

    ✓ Peer-reviewed Inflammation and the immune system ACS Chemical Neuroscience

    Key finding: We exposed primary rat ventral spinal cord neuronal cultures and rat spinal cord organotypic cultures to astrocyte-conditioned medium derived from primary mouse ALS astrocytes expressing mutant human SOD1 (SOD1 G93A -ACM) or from human-induced pluripotent stem cell (iPSC)-derived astrocytes carrying an ALS-causing mutation in SOD1 (SOD1 D90A -ACM) or an ALS/FTD-causing mutation in TDP-43 (TDP43 A90 V -ACM). +4 more findings

  25. 2025-07-17

    Parenchymal and Dyshoric Fibrillar Amyloid Pathology in the rTg-D Rat Model of Cerebral Amyloid Angiopathy Type-2

    ✓ Peer-reviewed Brain tissue and pathology American Journal Of Pathology

    Key finding: Cerebral proteomic analyses revealed that while rTg-D HEM rats and rTg-D HOM rats shared some common differentially expressed proteins compared with wild-type rats, rTg-D HOM rats exhibited many more elevated proteins. +2 more findings

Browse the library by subject, with the full score breakdown →